ArticleClinical & translational immunology2017

Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment.

Stefan Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.